FDA Adverse Event Malfunction Summary report: N

INTERMATE

MDR report key: 3043384 · Received April 9, 2013

Report

Report Number
1416980-2013-08810
Event Type
Malfunction
Date Received
April 9, 2013
Date of Event
August 3, 2012
Report Date
August 3, 2012
Manufacturer
BAXTER HEALTHCARE - IRVINE
Product Code
FRN
PMA / PMN Number
K910425
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). (B)(6). EVALUATION SUMMARY: BAXTER RECEIVED ONE SAMPLE FOR EVALUATION. THE REPORTED CONDITION OF A RUPTURE WAS NOT CONFIRMED. VISUAL EXAMINATION OF THE SAMPLE SHOWED NO SIGNS OF PHYSICAL ABNORMALITY. NO ROOT CAUSE WAS IDENTIFIED, AS NO EVIDENCE OF PRODUCT MALFUNCTION WAS OBSERVED. NO REPAIR WAS DONE, AS THIS IS A SINGLE-USE DEVICE WHICH WILL BE DISCARDED. NO OTHER OBSERVATIONS WERE NOTED ON THE UNIT. THE BATCH REVIEW REVEALED THAT ALL OF THE ACCEPTANCE CRITERIA WERE MET TO RELEASE THE LOT. THERE WERE NO NON-CONFORMANCES, FAILURES, REWORK, OR DEVIATIONS RELATED TO THE LOT. THERE WERE NO CHANGES TO SPECIFICATIONS, TEST METHODS, PROCESS, EQUIPMENT, OR RAW MATERIALS THAT COULD BE ASSOCIATED WITH THE REPORTED CONDITION. SINCE THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN, A 510K NUMBER CANNOT BE PROVIDED.

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

BAXTER (B)(4) RECEIVED A REPORT THAT AN ELASTOMERIC DEVICE HAD A RESERVOIR RUPTURE AND LEAK BEFORE PATIENT USE. THE DEVICE WAS FILLED WITH A SOLUTION 40 MG OF AMIKACIN IN 100 ML OF SALINE. THERE WAS NO PATIENT INVOLVEMENT; THEREFORE, NO PATIENT INJURY, MEDICAL INTERVENTION, OR ADVERSE REACTION IS ASSOCIATED WITH THE REPORTED CONDITION. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
144717 INTERMATE PUMP, INFUSION FRN BAXTER HEALTHCARE - IRVINE

Patients

Seq Age Sex Outcome Treatment
1